Interleukin-33 (IL-33) as a Diagnostic and Prognostic Factor in Traumatic Brain Injury

Interleukin-33 (IL-33) is a cytokine involved in interleukin-1 family. Role of IL-33 in immune system activation is well described in the literature. IL-33 has been identified as an endogenous alarm signal (alarmin) to alert various types of immune cells to trauma. In this narrative review, we aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Erenler, Ali Kemal, Baydin, Ahmet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199602/
https://www.ncbi.nlm.nih.gov/pubmed/32399302
http://dx.doi.org/10.1155/2020/1832345
_version_ 1783529179075051520
author Erenler, Ali Kemal
Baydin, Ahmet
author_facet Erenler, Ali Kemal
Baydin, Ahmet
author_sort Erenler, Ali Kemal
collection PubMed
description Interleukin-33 (IL-33) is a cytokine involved in interleukin-1 family. Role of IL-33 in immune system activation is well described in the literature. IL-33 has been identified as an endogenous alarm signal (alarmin) to alert various types of immune cells to trauma. In this narrative review, we aimed to underline the diagnostic and prognostic importance of IL-33 in trauma, particularly in brain trauma.
format Online
Article
Text
id pubmed-7199602
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-71996022020-05-12 Interleukin-33 (IL-33) as a Diagnostic and Prognostic Factor in Traumatic Brain Injury Erenler, Ali Kemal Baydin, Ahmet Emerg Med Int Review Article Interleukin-33 (IL-33) is a cytokine involved in interleukin-1 family. Role of IL-33 in immune system activation is well described in the literature. IL-33 has been identified as an endogenous alarm signal (alarmin) to alert various types of immune cells to trauma. In this narrative review, we aimed to underline the diagnostic and prognostic importance of IL-33 in trauma, particularly in brain trauma. Hindawi 2020-01-10 /pmc/articles/PMC7199602/ /pubmed/32399302 http://dx.doi.org/10.1155/2020/1832345 Text en Copyright © 2020 Ali Kemal Erenler and Ahmet Baydin. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Erenler, Ali Kemal
Baydin, Ahmet
Interleukin-33 (IL-33) as a Diagnostic and Prognostic Factor in Traumatic Brain Injury
title Interleukin-33 (IL-33) as a Diagnostic and Prognostic Factor in Traumatic Brain Injury
title_full Interleukin-33 (IL-33) as a Diagnostic and Prognostic Factor in Traumatic Brain Injury
title_fullStr Interleukin-33 (IL-33) as a Diagnostic and Prognostic Factor in Traumatic Brain Injury
title_full_unstemmed Interleukin-33 (IL-33) as a Diagnostic and Prognostic Factor in Traumatic Brain Injury
title_short Interleukin-33 (IL-33) as a Diagnostic and Prognostic Factor in Traumatic Brain Injury
title_sort interleukin-33 (il-33) as a diagnostic and prognostic factor in traumatic brain injury
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199602/
https://www.ncbi.nlm.nih.gov/pubmed/32399302
http://dx.doi.org/10.1155/2020/1832345
work_keys_str_mv AT erenleralikemal interleukin33il33asadiagnosticandprognosticfactorintraumaticbraininjury
AT baydinahmet interleukin33il33asadiagnosticandprognosticfactorintraumaticbraininjury

Ejemplares similares